The ApoE3-Ch mutation strongly protects against early-onset AD, as evidenced by a homozygous index patient who developed only mild dementia much later in life than expected, highlighting the importance of studying rare ApoE variants in AD pathogenesis and protection (Arboleda-Velasquez et al., 2019). Here, APOE is linked to Alzheimer disease.